Alnylam Pharmaceuticals
ALNY
#621
Rank
HK$254.10 B
Marketcap
HK$1,963
Share price
4.50%
Change (1 day)
70.24%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company